Key result
Elevated C-reactive protein-triglyceride glucose index linked to ~42% higher incident CVD risk.
Why the study?
Discovering new risk indicators and their mechanisms is critical for preventing cardiovascular and cerebrovascular diseases, which rank first in mortality among Chinese residents. This study explored the association between the C-reactive protein-triglyceride glucose index and adult CVD risk, alongside the mediating effects of homocysteine and blood pressure.
Does a higher baseline C-reactive protein-triglyceride glucose index (CTI) increase the incidence of cardiovascular and cerebrovascular diseases in community-dwelling Chinese adults free of baseline CVD, and is this association mediated by blood pressure or homocysteine?
Cohort (n=7,947)
Yes
Does a higher baseline C-reactive protein-triglyceride glucose index (CTI) increase the incidence of cardiovascular and cerebrovascular diseases in community-dwelling Chinese adults free of baseline CVD, and is this association mediated by blood pressure or homocysteine?
Answers are grounded in this paper and cite their sources.
The C-reactive protein-triglyceride glucose index (CTI) is independently and linearly associated with an increased risk of incident cardiovascular and cerebrovascular diseases in Chinese adults, an effect partially mediated by elevated systolic and diastolic blood pressure rather than homocysteine.
Cardiovascular and cerebrovascular diseases (CVD) rank first in mortality among Chinese residents. Discovering new risk indicators and their mechanisms is critical for CVD prevention. This study explored the association between the C-reactive protein-triglyceride glucose index (CTI) and adult CVD risk, as well as the mediating effect of homocysteine (HCY) and blood pressure (BP). This prospective cohort recruited 7,947 CVD-free adults from the 2019–2025 Pudong New Area chronic disease survey. Baseline detections covered C-reactive protein (CRP), triglyceride (TG), and fasting blood glucose (FBG) to calculate CTI, which was stratified into four quartiles. Participants were followed up to June 2025 to record new-onset CVD, stroke, and coronary heart disease (CHD). Cox regression evaluated CTI, HCY, and BP’s links with CVD events; restricted cubic spline (RCS) curves tested nonlinear correlations. Bootstrap analysis with 3,000 resamples was adopted for mediation effect assessment. A total of 1360 CVD events occurred during follow-up, consisting of 519 strokes and 1021 CHD cases, with CVD incidence density rising markedly with age ( P -trend < 0.05). After adjusting for age, gender, education, and other confounders, participants in the highest CTI quartile (Q4 ≥ 9.246) showed a 41.5% higher CVD risk than those in the lowest quartile (Q1 < 8.067) (HR = 1.415, 95% CI: 1.188–1.685, P < 0.001). Hypertension independently elevated CVD risk (HR = 1.830, 95%CI: 1.631–2.054, P < 0.001),while hyperhomocysteinemia(HHCY) showed no independent association with CVD risk in our analysis(HR = 0.980, 95%CI:0.862–1.114, P = 0.756). RCS models verified approximately linear associations of CTI, SBP and DBP with CVD (all P for nonlinear > 0.05). Mediation analysis revealed that BP partially mediated the relationship between CTI and CVD, with significant indirect effects through SBP (indirect effect = 0.043, 95% CI: 0.025–0.064) and DBP (indirect effect = 0.030, 95% CI: 0.008–0.052). The proportion of the total effect mediated was 26.39% (95% CI: 13.36%–46.27%) for SBP and 18.25% (95% CI: 4.63%–36.58%) for DBP, respectively. CTI and BP were independently associated with increased CVD risk, with SBP and DBP partially mediating the CTI–CVD association. HHCY showed no independent association, suggesting HCY is not a causal risk factor in this study.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) conducted a cohort in Cardiovascular and cerebrovascular diseases (CVD) (n=7,947). Highest quartile of C-reactive protein-triglyceride glucose index (CTI Q4 ≥ 9.246) vs. Lowest quartile of C-reactive protein-triglyceride glucose index (CTI Q1 < 8.067) was evaluated on Incident cardiovascular and cerebrovascular disease (composite of stroke and coronary heart disease) (HR 1.415, 95% CI 1.188-1.685, p=<0.001). Elevated C-reactive protein-triglyceride glucose index (CTI Q4 vs Q1) increased incident CVD risk by 41.5% (HR 1.415, 95% CI 1.188-1.685, P<0.001), partially mediated by blood pressure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: